Multiple Large Tumefactive MS Plaques in a Young Man: A Diagnostic Enigma and Therapeutic Challenge
Tumefactive demyelinating lesion is defined as large solitary demyelinating lesion with imaging characteristics mimicking neoplasm. These atypical features include size more than 2 cm, mass effect, edema, and/or ring enhancement. Distinguishing tumefactive lesions from other etiologies of intracrani...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2012-01-01
|
Series: | Case Reports in Radiology |
Online Access: | http://dx.doi.org/10.1155/2012/363705 |
id |
doaj-8999bf0d10dc47b294ef304378ea3af0 |
---|---|
record_format |
Article |
spelling |
doaj-8999bf0d10dc47b294ef304378ea3af02020-11-24T23:03:46ZengHindawi LimitedCase Reports in Radiology2090-68622090-68702012-01-01201210.1155/2012/363705363705Multiple Large Tumefactive MS Plaques in a Young Man: A Diagnostic Enigma and Therapeutic ChallengeHossein Kalanie0Ali Amini Harandi1Reza Bakhshandehpour2Daryoosh Heidari3Mehr Hospital, Shahid Beheshti University of Medical Sciences, Tehran, IranLoghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, IranShahid Beheshti University of Medical Sciences, Tehran, IranMehr Hospital, Shahid Beheshti University of Medical Sciences, Tehran, IranTumefactive demyelinating lesion is defined as large solitary demyelinating lesion with imaging characteristics mimicking neoplasm. These atypical features include size more than 2 cm, mass effect, edema, and/or ring enhancement. Distinguishing tumefactive lesions from other etiologies of intracranial space occupying lesions is essential to avoid inadvertent surgical or toxic chemotherapeutic intervention. Symptoms are generally atypical for multiple sclerosis (MS) and usually related to the pressure of a focal mass lesion without a history of MS. The clinical presentation and MRI appearance of these lesions often lead to biopsy. Here, we present a young man with fulminating neurological symptoms and multiple large tumefactive lesions on either hemisphere. Since patient and parents were not agreed on brain biopsy, a course of steroid therapy was commenced which ended to considerable improvement and confirmed the diagnosis of tumefactive MS. Thirteen months later, he experienced another relapse when his treatment was continued by weekly intramuscular injection of interferon b1a (Avonex). Two further MRIs showed shrinkage of tumefactive plaques and resolution of edema in the periphery of lesions.http://dx.doi.org/10.1155/2012/363705 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Hossein Kalanie Ali Amini Harandi Reza Bakhshandehpour Daryoosh Heidari |
spellingShingle |
Hossein Kalanie Ali Amini Harandi Reza Bakhshandehpour Daryoosh Heidari Multiple Large Tumefactive MS Plaques in a Young Man: A Diagnostic Enigma and Therapeutic Challenge Case Reports in Radiology |
author_facet |
Hossein Kalanie Ali Amini Harandi Reza Bakhshandehpour Daryoosh Heidari |
author_sort |
Hossein Kalanie |
title |
Multiple Large Tumefactive MS Plaques in a Young Man: A Diagnostic Enigma and Therapeutic Challenge |
title_short |
Multiple Large Tumefactive MS Plaques in a Young Man: A Diagnostic Enigma and Therapeutic Challenge |
title_full |
Multiple Large Tumefactive MS Plaques in a Young Man: A Diagnostic Enigma and Therapeutic Challenge |
title_fullStr |
Multiple Large Tumefactive MS Plaques in a Young Man: A Diagnostic Enigma and Therapeutic Challenge |
title_full_unstemmed |
Multiple Large Tumefactive MS Plaques in a Young Man: A Diagnostic Enigma and Therapeutic Challenge |
title_sort |
multiple large tumefactive ms plaques in a young man: a diagnostic enigma and therapeutic challenge |
publisher |
Hindawi Limited |
series |
Case Reports in Radiology |
issn |
2090-6862 2090-6870 |
publishDate |
2012-01-01 |
description |
Tumefactive demyelinating lesion is defined as large solitary demyelinating lesion with imaging characteristics mimicking neoplasm. These atypical features include size more than 2 cm, mass effect, edema, and/or ring enhancement. Distinguishing tumefactive lesions from other etiologies of intracranial space occupying lesions is essential to avoid inadvertent surgical or toxic chemotherapeutic intervention. Symptoms are generally atypical for multiple sclerosis (MS) and usually related to the pressure of a focal mass lesion without a history of MS. The clinical presentation and MRI appearance of these lesions often lead to biopsy. Here, we present a young man with fulminating neurological symptoms and multiple large tumefactive lesions on either hemisphere. Since patient and parents were not agreed on brain biopsy, a course of steroid therapy was commenced which ended to considerable improvement and confirmed the diagnosis of tumefactive MS. Thirteen months later, he experienced another relapse when his treatment was continued by weekly intramuscular injection of interferon b1a (Avonex). Two further MRIs showed shrinkage of tumefactive plaques and resolution of edema in the periphery of lesions. |
url |
http://dx.doi.org/10.1155/2012/363705 |
work_keys_str_mv |
AT hosseinkalanie multiplelargetumefactivemsplaquesinayoungmanadiagnosticenigmaandtherapeuticchallenge AT aliaminiharandi multiplelargetumefactivemsplaquesinayoungmanadiagnosticenigmaandtherapeuticchallenge AT rezabakhshandehpour multiplelargetumefactivemsplaquesinayoungmanadiagnosticenigmaandtherapeuticchallenge AT daryooshheidari multiplelargetumefactivemsplaquesinayoungmanadiagnosticenigmaandtherapeuticchallenge |
_version_ |
1725632184352505856 |